1
Sagy Pundak Mintz
Sagy Mintz, Robert West, Christos Kondilis: System and Method for simulating an electronic trading environment. Mbhb Trading Technologies, November 16, 2006: US20060259399-A1

Market data is recorded from a real live exchange. The recording data can be played back in real time or delayed, in any manner, to simulate the recorded market. Moreover, one or more users can participate in the simulated market just as if they were participating in a real-live market. The system p ...


2
Chris Blackburn
Christopher W Blackburn, Robert T Davis, Christopher J Frattinger, Jeremy Hornik, Sue Ruebusch, Alfred Thomas, William Wadleigh, Terry D Warkentin: Ordering, delivering, and licensing wager gaming content. Schwegman Lundberg Woessner & Kluth Pa, November 16, 2006: US20060258428-A1

A system and method for viewing and ordering wager gaming content utilizes a network server to provide an interface to a user coupled to the network. In one embodiment, the server is an Internet web based server, and the user is a thin client, using an Internet browser to view and select wager gamin ...


3
Martti Jyrki: Services in a communication system. Nokia Corporation, Martti Jyrki, RUUSKANEN Juha Pekka, November 16, 2006: WO/2006/120558 (130 worldwide citation)

A user device (20) is provided with information relating to a service wherein content is communicated to the user device via an access system provided by a communications network (22). In the method information regarding access charges from a charging entity (26) associated with the access system is ...


4
Hansen Steffen, Nielsen Ole Christian, Bengtsson Henrik, Jensen Jens Peter: Medical device adapted to detect disengagement of a transcutaneous device. Novo Nordisk, Hansen Steffen, Nielsen Ole Christian, Bengtsson Henrik, Jensen Jens Peter, NOVO NORDISK, November 16, 2006: WO/2006/120253 (92 worldwide citation)

The present invention provides a medical device comprising a transcutaneous device. The medical device further comprises a controller for detecting a first condition representative of the transcutaneous device being arranged in a subcutaneous first position, and for detecting a second condition repr ...


5
Heyes Keith James, Bramley Hugh Christopher, Reeves Mark, Jervis Mark, Ward Trevor: Dialysis machine. Imi Vision, Heyes Keith James, Bramley Hugh Christopher, Reeves Mark, Jervis Mark, Ward Trevor, BARKER BRETTELL, November 16, 2006: WO/2006/120415 (88 worldwide citation)

A disposable cartridge (10) or use in a hemodialysis machine (1) has a blood flowpath for carrying a volume of blood to be treated in a dialyser and a dialysate flowpath, isolated from the blood flowpath, for delivering a flow of dialysate solution through the dialyser. The cartridge (10) is receive ...


6
Gunic Esmir, Chow Suetying, Rong Frank: Phosphoramidate prodrugs for treatment of viral infection. Valeant Research & Development, Gunic Esmir, Chow Suetying, Rong Frank, REESE Heidi L, November 16, 2006: WO/2006/121820 (68 worldwide citation)

The invention concerns 2'-methyl ribonucleotide phosphoramidates which are neutral prodrugs which are converted in vivo to 2'- methyl ribonucleotide triphosphates. These compounds are useful in the treatment of viral infection. Of particular interest are prodrugs of a methylsulfonylhydrazinyl purine ...


7
Scott Jordan, Reed Robert, Reed Gloria: Devices and methods for tracking, locating and providing protection to individuals. Smartwear Technologies, Scott Jordan, Reed Robert, Reed Gloria, HOSTETLER Michael J, November 16, 2006: WO/2006/122041 (67 worldwide citation)

Described herein are devices and methods for tracking, locating and/or providing protection to individuals. Such devices and methods incorporate an RFlD tag that are located with the clothing of the individual. An RFID reader and a device for data processing can also be used with such devices and me ...


8

9

10
Korman Alan J, Srinivasan Mohan, Wang Changyu, Selby Mark J, Chen Bing, Cardarelli Josephine M: Human monoclonal antibodies to programmed death 1(pd-1) and methods for treating cancer using anti-pd-1 antibodies alone or in combination with other immunotherapeutics. Ono Pharmaceutical, Medarex, Korman Alan J, Srinivasan Mohan, Wang Changyu, Selby Mark J, Chen Bing, Cardarelli Josephine M, NAITO Teruo, November 16, 2006: WO/2006/121168 (62 worldwide citation)

The present invention provides isolated monoclonal antibodies, particularly human monoclonal antibodies, that specifically bind to PD-1 with high affinity. Nucleic acid molecules encoding the antibodies of the invention, expression vectors, host cells and methods for expressing the antibodies of the ...